PUBLISHER: Market Research Future | PRODUCT CODE: 1777258
PUBLISHER: Market Research Future | PRODUCT CODE: 1777258
Global Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Industry Forecast till 2035
Industry Overview
The global ischemic stroke surgery market reached USD 2,291.16 million in 2021 and is projected to achieve USD 7,266.15 million with a CAGR of 8.70% by the end of 2035. Ischemic stroke surgery is a medical procedure used to remove blood clots and restore blood flow to the brain. It helps reduce brain damage and improves recovery chances in patients suffering from acute ischemic stroke.
An increase in physical inactivity and poor lifestyle choices is pushing the demand in the global ischemic stroke surgery market. Advanced surgical methods and tools are making treatments more effective. Patients are also choosing less invasive procedures for quicker recovery.
The presence of limited medical infrastructure and a lack of experienced professionals is slowing the progress of the global ischemic stroke surgery industry. Still, with more research and investment, the ischemic stroke surgery market is finding new paths for development.
Industry Segmentations
In terms of product type, the global market is divided into catheters, aspiration systems, guidewires, microcatheters, and others.
Based on the type of surgery, the global ischemic stroke surgery market is classified into Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, and others.
The global ischemic stroke surgery market is segmented based on the end-users, including hospitals and clinics, ambulatory surgical centers, and others.
The ischemic stroke surgery market is still expanding rapidly in North America due to a large number of stroke cases and rising utilization of cutting-edge techniques like endovascular thrombectomy. An increasing senior population, more awareness, and technological advancements are all driving market expansion.
New research and successful treatments like thrombectomy are driving the growth of the ischemic stroke surgery market in Europe. The region's stroke treatment results are improving because of strong support for healthcare innovation.
The ischemic stroke surgery market is broadening quickly in the Asia-Pacific as governments increase their spending on research and healthcare. New treatments are becoming more widely available in nations like South Korea, Japan, and India, which is helping patients recover.
Latin America, the Middle East, and Africa are experiencing a rise in stroke-related illnesses, creating a higher demand for surgery. Better medical infrastructure and health programs are helping these regions grow in the global market.
Major players in the global ischemic stroke surgery market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Johnson & Johnson Services Inc., Koninklijke Philips N.V., Stryker, Imperative Care, Penumbra, Inc., and Phenox GmbH.